SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-24-014676
Filing Date
2024-04-15
Accepted
2024-04-15 17:25:42
Documents
63
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm   iXBRL 10-Q/A 1550857
2 ex31-1.htm EX-31.1 18767
3 ex31-2.htm EX-31.2 18077
4 ex32-1.htm EX-32.1 7801
5 ex32-2.htm EX-32.2 7769
  Complete submission text file 0001493152-24-014676.txt   7821171

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE aeha-20230331.xsd EX-101.SCH 55531
7 XBRL CALCULATION FILE aeha-20230331_cal.xml EX-101.CAL 48035
8 XBRL DEFINITION FILE aeha-20230331_def.xml EX-101.DEF 304491
9 XBRL LABEL FILE aeha-20230331_lab.xml EX-101.LAB 408197
10 XBRL PRESENTATION FILE aeha-20230331_pre.xml EX-101.PRE 358466
67 EXTRACTED XBRL INSTANCE DOCUMENT form10-qa_htm.xml XML 1224402
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-40793 | Film No.: 24845540
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)